South Rampart Pharma Announces Appointment of Josh Blacher as Chief Financial Officer
NEW ORLEANS, Aug. 16, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced the appointment of Josh Blacher as the company's Chief Financial Officer.
- NEW ORLEANS, Aug. 16, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced the appointment of Josh Blacher as the company's Chief Financial Officer.
- Mr. Blacher brings to South Rampart Pharma over twenty years of leadership experience in senior positions in the healthcare and capital markets sectors.
- Hernan Bazan, M.D., F.A.C.S., CEO and Co-Founder of South Rampart Pharma and The Endowed John Ochsner Professor of Surgery at the Ochsner Clinic, commented, "We are thrilled to welcome Josh to our team.
- "I'm elated to join the South Rampart Pharma team to help it accomplish its corporate and clinical objectives."